Biocardia to host q3 2022 financial results and corporate update conference call on november 9, 2022

Sunnyvale, calif., nov. 02, 2022 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the three and nine months ended september 30, 2022 and provide a corporate update by conference call on wednesday, november 9, 2022 at 4:30 pm et. following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
BCDA Quant Ranking